The Centre for Molecular Pathology is a world-class research facility that will revolutionise how we diagnose and treat cancer. It opened in November 2012.
The Centre brings together clinicians, geneticists, pathologists and scientists from The Royal Marsden and The Institute of Cancer Research.
Working side by side, they will be able to better understand different tumour types and the most effective way to treat them, leading to the development of personalised treatment plans faster than ever before.
Watch the video
Personalised cancer treatment
We now know that patients with the same type of cancer may respond differently to the same treatment. This is due to differing genetic mutations in individual tumours and the patient’s own individual genetic profile.
Molecular diagnosis uses this information to help identify who may benefit from which specific therapies. When using molecular diagnosis, treatment can be tailored to suit individual patients’ needs rather than using the traditional one-size-fits-all approach of conventional chemotherapy.
The Royal Marsden is already leading the way in providing patients with routine molecular diagnosis for selected tumour types. The Centre for Molecular Pathology will enable it to expand this ground-breaking work to include all tumour types and revolutionise the diagnosis and treatment of cancer as we know it.
With the help of supporters, The Royal Marsden Cancer Charity contributed £2.3 million towards building the CMP, which was developed in partnership with The Institute of Cancer Research.
Support The Royal Marsden and you’re investing in a future beyond cancer for you and everyone you know.
Set up a regular donation by direct debit
Make a one-off donation today